Taoufik Alsaadi

Abu Dhabi, AZ, United Arab Emirates

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Impact of Migraine and its Management in 5 Gulf Countries: Results of Social Media Platforms Listening Study.

Impact of Migraine and its Management in 5 Gulf Countries: Results of Social Media Platforms Listening Study.

Journal: JMIR formative research

Published: August 13, 2026

Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE.

Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE.

Journal: Neurology and therapy

Published: April 08, 2026

Transcultural headache medicine: A framework for integrating cultural contexts into headache science and care - a call to action from the International Headache Society.

Transcultural headache medicine: A framework for integrating cultural contexts into headache science and care - a call to action from the International Headache Society.

Journal: Cephalalgia : an international journal of headache

Published: March 31, 2026

Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry-Based Real-World Study.

Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry-Based Real-World Study.

Journal: European journal of neurology

Published: September 27, 2025

Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH study.

Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH study.

Journal: Headache

Published: September 24, 2025

A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine.

A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine.

Journal: Cephalalgia : an international journal of headache

Published: July 30, 2025

Bridging CGRP mAbs with Gepants: An innovative approach to address the wearing-off phenomenon.

Bridging CGRP mAbs with Gepants: An innovative approach to address the wearing-off phenomenon.

Journal: Clinical neurology and neurosurgery

Published: July 25, 2025

Clinical factors associated with perampanel retention, response, seizure freedom and tolerability: real-world evidence from the PERMIT Extension study.

Clinical factors associated with perampanel retention, response, seizure freedom and tolerability: real-world evidence from the PERMIT Extension study.

Journal: Therapeutic advances in neurological disorders

Published: March 04, 2025

Consensus guidelines on the diagnosis and management of myasthenia gravis by the Saudi Arabia Neuromuscular and Electrodiagnostic Medicine and neuromuscular specialists from the Gulf Cooperation Council region.

Consensus guidelines on the diagnosis and management of myasthenia gravis by the Saudi Arabia Neuromuscular and Electrodiagnostic Medicine and neuromuscular specialists from the Gulf Cooperation Council region.

Journal: Therapeutic advances in neurological disorders

Published: December 25, 2024

Prevalence, Treatment, and Unmet Needs of Migraine in the Middle East: A Systematic Review.

Prevalence, Treatment, and Unmet Needs of Migraine in the Middle East: A Systematic Review.

Journal: Pain and therapy

Published: September 24, 2024

Perampanel for the treatment of Asian people with epilepsy: Real-world evidence from the PERMIT extension study.

Perampanel for the treatment of Asian people with epilepsy: Real-world evidence from the PERMIT extension study.

Journal: Journal of the neurological sciences

Published: May 03, 2024

Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study.

Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study.

Journal: Neurology international

Published: January 12, 2024

Showing 1-12 of 64

Last Updated: 09/26/2026